{"database": "lobbying", "table": "lobbying_activities", "rows": [[3138896, "ac131157-dc64-4db0-9201-6e6e558d3b4b", "Q1", "AUBURN HEALTH STRATEGIES, LLC", 292697, "AOAC INTERNATIONAL", 2024, "first_quarter", "CSP", "methods development and quality measurements in analytical sciences for cannabis-derived products and for cosmetics", "Food & Drug Administration (FDA),Natl Institutes of Health (NIH)", 0, 0, "2024-04-02T10:53:55-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3138896"], "units": {}, "query_ms": 58.28363395994529, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}